Furthermore, anti-VEGF ocular therapy can produce tachyphylaxis, and systemic side effects have been reported, including hypertension, stroke, thromboembolic events, myocardial infarction, gastrointestinal perforations and kidney disease [201]. The gene discussed is VEGFA; the disease is hypertensive disorder.